CFTR Modulators
The cystic fibrosis transmembrane regulatory conductance (CFTR)
modulators have been exciting to watch over the years, with no exception
in 2021, where additional advances were published, expanding eligibility
to younger ages and additional mutations while also garnering a better
understanding of the long-term effect on outcomes for people with CF
(PwCF).